These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6549259)

  • 1. Intracerebroventricular application of a vasopressin antagonist peptide prevents the behavioral actions of vasopressin.
    Ettenberg A
    Behav Brain Res; 1984 Dec; 14(3):201-11. PubMed ID: 6549259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?
    Ettenberg A; van der Kooy D; Le Moal M; Koob GF; Bloom FE
    Behav Brain Res; 1983 Mar; 7(3):331-50. PubMed ID: 6838716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin.
    Ettenberg A; Le Moal M; Koob GF; Bloom FE
    Pharmacol Biochem Behav; 1983 Apr; 18(4):645-7. PubMed ID: 6867069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
    Lebrun C; Le Moal M; Koob GF; Bloom FE
    Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats.
    Packard MG; Ettenberg A
    Regul Pept; 1985 May; 11(1):51-63. PubMed ID: 4011956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of aversive stimulus properties of vasopressin.
    Bluthé RM; Dantzer R; Mormède P; Le Moal M
    Psychopharmacology (Berl); 1985; 87(2):238-41. PubMed ID: 3931152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis.
    Le Moal M; Dantzer R; Mormède P; Baduel A; Lebrun C; Ettenberg A; van der Kooy D; Wenger J; Deyo S; Koob GF
    Psychoneuroendocrinology; 1984; 9(4):319-41. PubMed ID: 6514931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged inhibition of pressor response to vasopressin by a potent specific antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid) 2-(O-methyl)tyrosine]arginine-vasopressin.
    Pang CC; Leighton KM
    Can J Physiol Pharmacol; 1981 Sep; 59(9):1008-12. PubMed ID: 6895346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.
    Koob GF; Le Moal M; Gaffori O; Manning M; Sawyer WH; Rivier J; Bloom FE
    Regul Pept; 1981 Jun; 2(3):153-63. PubMed ID: 7255768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ; Rigter H; Martinez JL; Koob GF; Le Moal M; Bloom FE
    Life Sci; 1984 Oct; 35(14):1505-12. PubMed ID: 6482669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of vasopressin to enhance memory in a passive avoidance task in rats.
    Sahgal A; Keith AB; Wright C; Edwardson JA
    Neurosci Lett; 1982 Jan; 28(1):87-92. PubMed ID: 7063145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task.
    Vawter MP; De Wied D; Van Ree JM
    Neuropeptides; 1997 Oct; 31(5):489-94. PubMed ID: 9413027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin.
    Thornhill JA; Pittman QJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):174-82. PubMed ID: 1968777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D; Gaffori O; Van Ree JM; De Jong W
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmotic stress mimics effects of vasopressin on learned behaviour.
    Koob GF; Dantzer R; Rodriguez F; Bloom FE; Le Moal M
    Nature; 1985 Jun 27-Jul 3; 315(6022):750-2. PubMed ID: 4010780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine vasopressin, stress, and memory.
    Koob GF; Lebrun C; Martinez JL; Dantzer R; Le Moal M; Bloom FE
    Ann N Y Acad Sci; 1985; 444():194-202. PubMed ID: 3860087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential actions of neuronal and hormonal vasopressin on blood pressure and baroreceptor reflex sensitivity in rats.
    Unger T; Rohmeiss P; Demmert G; Luft FC; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S81-6. PubMed ID: 2434779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.